← SynDRA
IXABEPILONE
SynDRA canonical compound SYN0023603 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | TUBB |
| Mechanism of action | microtubule stabilizing agent |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
- TUBB
- BCL2
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
- TUBB4B
- TUBB6
- TUBB8
Mechanisms of action (all sources)
- microtubule stabilizing agent
- TUBB INHIBITOR
- TUBB1 INHIBITOR
- TUBB2A INHIBITOR
- TUBB2B INHIBITOR
- TUBB3 INHIBITOR
- TUBB4A INHIBITOR
- TUBB4B INHIBITOR
- TUBB6 INHIBITOR
- TUBB8 INHIBITOR
Drug classes
ATC classes
- L01D · CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Cross-references
Synonyms
- Azaepothilone B
- ixempra
- BMS-247550
- Ixabepilona
- Azaepothilone b
- Ixempra
- BMS-247550-01
- NSC-747973
- Ixempra kit
- Ixempra (TN)
- BMS 247550
- Aza-epothilone B
- BMS 247550-1
- NSC 747973
- CHEBI:63605
- K27005NP0A
- NSC747973
- 17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1S,3S,7S,10R,11S,12S,16R)-
- 1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-((1E)-1-methyl-2-(2-methylthiazol-4-yl)ethenyl)-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione
- Ixabepilone [INN]
- (1~{S},3~{S},7~{S},10~{R},11~{S},12~{S},16~{R})-8,8,10,12,16-pentamethyl-3-[(~{E})-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-7,11-bis(oxidanyl)-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
- (1R,5S,6S,7R,10S,14S,16S)-6,10-DIHYDROXY-1,5,7,9,9-PENTAMETHYL-14-((E)-1-(2-METHYL-1,3-THIAZOL-4-YL)PROP-1-EN-2-YL)-17-OXA-13-AZABICYCLO(14.1.0)HEPTADECANE-8,12-DIONE
- (1R,5S,6S,7R,10S,14S,16S)-6,10-dihydroxy-1,5,7,9,9-pentamethyl-14-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-13-azabicyclo[14.1.0]heptadecane-8,12-dione
- Ixempra (TM)
- 16-Aza-epothilone B
- IXABEPILONE [MI]
- IXABEPILONE [JAN]
- IXABEPILONE [HSDB]
- IXABEPILONE [USAN]
- IXABEPILONE [VANDF]
- SCHEMBL8386
- IXABEPILONE [MART.]
- IXABEPILONE [USP-RS]
- IXABEPILONE [WHO-DD]
- UNII-K27005NP0A
- Ixabepilone (JAN/USAN/INN)
- Ixabepilone [USAN:INN:JAN]
- GTPL6824
Reported adverse events
- Abdominal pain
- Alopecia
- Chest pain
- Constipation
- Cough
- Dehydration
- Dizziness
- Fatigue
- Febrile neutropenia
- Headache
- Hypersensitivity
- Infection
Look up IXABEPILONE in the interactive SynDRA portal →